Table 2 Baseline characteristic of survivors and non-survivors (30 days)
Survivors 30-days n = 117 (69) | Non-survivors 30-days n = 52 (31) | P-value | |
|---|---|---|---|
Characteristics | |||
Age yrs. (range/± SD) | 40,8 (±14.2) | 47,2 (±11.7) | 0.005 |
Male gender (%) | 65 (56) | 33 (63) | 0.337 |
Female gender (%) | 52 (44) | 19 (37) | |
BMI kg/m2 (±SD) | 28,1 (±7.7) | 26,7 (± 6.2) | 0.348 |
ECMO-Therapy (%) | 31 (27) | 20 (38) | 0.099 |
Dialysis (%) | 49 (42) | 34 (65) | 0.002 |
Antibiotics before ICU admission (%) | 97 (83) | 45 (87) | 0.552 |
Cardiovascular disease (%) | 14 (12) | 11 (21) | 0.120 |
Prior lung disease (%) | 11 (9) | 9 (17) | 0.142 |
SAPS II (±SD) | 43 (±19.0) | 53 (±19.1) | 0.003 |
LIS (±SD) | 3,2 (±0.56) | 3,2 (±0.56) | 0.702 |
SOFA (±SD) | 12 (±5.5) | 15 (±5.8) | <0.001 |
Horowitz-index upon ICU admission (±SD) | 158 (±122.5) | 140 (±98.5) | 0.480 |